Ampio Pharmaceuticals Navigation
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Overview
    • Ampion
    • About Osteoarthritis
    • Optina
    • About Diabetic Macular Edema
  • Partnering
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Overview
    • Ampion
    • About Osteoarthritis
    • Optina
    • About Diabetic Macular Edema
  • Partnering
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
Contact Us

Contact Us

Ampio Pharmaceuticals, Inc.
373 Inverness Parkway, Suite 200
Englewood, CO 80112 USA

Main office: +1 720 437 6500

General email inquiries: info@ampiopharma.com
Partnering email inquiries: partnering@ampiopharma.com

Ampion™

Ampion™ for the treatment of pain due to osteoarthritis of the knee.

Learn About Ampion

Optina™

Optina™ for the treatment of Diabetic Macular Edema.

Learn About Optina

Real Time Quote

Latest News

Ampio Pharmaceuticals Announces Closing of $12 Million Public Offering

June 19, 2019

Ampio Regulatory and Clinical Update

June 14, 2019

Ampio Clinical, Regulatory and Corporate Update

May 22, 2019
member-logo-85

© 2019 Ampio Pharmaceuticals Inc.

373 Inverness Parkway, Suite 200
Englewood, CO 80112 USA

Privacy Policy

Main office: +1 720 437 6500
Fax: +1 720 437 6501

General email inquiries: info@ampiopharma.com

  • Home
  • About Us
  • Pipeline
  • Partnering
  • Investors
  • News
  • Contact Us